DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.69
-0.05 (-0.57%)
At close: Oct 27, 2026, 4:00 PM EDT
8.69
0.00 (0.00%)
After-hours: Oct 27, 2026, 7:30 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $468.61 million as of October 27, 2026. It is the 14,916th most valuable company in the world and the 2,778th biggest in the United States. Its market cap has increased by 31.78% in one year.
Market Cap
468.61M
Enterprise Value
425.30M
1-Year Change
31.78%
Global Rank
Country Rank
#2,778 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $468.61M, an increase of 1,176.88%. That is a compound annual growth rate of 38.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 468.61M | 13.06% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 506.01M |
| Entera Bio | 497.42M |
| Oculis Holding AG | 491.39M |
| CytomX Therapeutics | 484.83M |
| Arvinas | 477.97M |
| Surrozen | 477.27M |
| Monopar Therapeutics | 473.48M |
| Phathom Pharmaceuticals | 471.81M |